Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deruo Liu

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
Journal of Thoracic Disease|August 18, 2020
Combining node location and node ratio as a prognostic factor for surgical resected non-small cell lung cancer: a population-based studyHuajie Xing, Mengyu Hu, Jingyu Chen, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 7, 2025
What is the optimal duration of neoadjuvant chemoimmunotherapy for resectable non-small cell lung cancer (NSCLC)?: a real-world studyZhoujunyi Tian, Haoshuai Yang, Jin Zhang, et al.
Experimental and Molecular Pathology|December 19, 2015
Promoter methylation of APC and RAR-β genes as prognostic markers in non-small cell lung cancer (NSCLC)Hongxiang Feng, Zhenrong Zhang, Xin Qing, et al.
Journal of Thoracic Disease|December 7, 2020
Charlson comorbidity index as a predictor of short-term outcomes after pulmonary resectionWeipeng Shao, Zhenrong Zhang, Jun Zhang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 14, 2010
[Effects of multiple factors on the prognosis of pIIIa/N2 patients with non-small cell lung cancer]Zhenrong Zhang, Deruo Liu, Yongqing Guo, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 4, 2010
Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2)Qianli Ma, Deruo Liu, Yongqing Guo, et al.
Pathology, Research and Practice|May 16, 2022
E2F1-activated LINC01224 drives esophageal squamous cell carcinoma cell malignant behaviors via targeting miR-6884-5p/DVL3 axis and activating Wnt/β-catenin signaling pathwayGuangliang Qiang, Qiduo Yu, Kunsong Su, et al.
Translational Cancer Research|February 4, 2022
Knockdown of actin-like 8 inhibits cell proliferation by regulating FOXM1, STMN1, PLK1, and BIRC5 in lung adenocarcinoma A549 cellsShanwu Ma, Guangliang Qiang, Weipeng Shao, et al.
The Annals of Thoracic Surgery|August 6, 2013
Extensive invasion of the left atrium by lung cancerQianli Ma, Deruo Liu, Peng Liu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|March 29, 2018
[Impact of Chronic Obstructive Pulmonary Disease on Risk of Recurrence in Patients with Resected Non-small Cell Lung Cancer]Guangliang Qiang, Qiduo Yu, Chaoyang Liang, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Journal of Thoracic Disease|August 18, 2020
Combining node location and node ratio as a prognostic factor for surgical resected non-small cell lung cancer: a population-based studyHuajie Xing, Mengyu Hu, Jingyu Chen, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 7, 2025
What is the optimal duration of neoadjuvant chemoimmunotherapy for resectable non-small cell lung cancer (NSCLC)?: a real-world studyZhoujunyi Tian, Haoshuai Yang, Jin Zhang, et al.
Experimental and Molecular Pathology|December 19, 2015
Promoter methylation of APC and RAR-β genes as prognostic markers in non-small cell lung cancer (NSCLC)Hongxiang Feng, Zhenrong Zhang, Xin Qing, et al.
Journal of Thoracic Disease|December 7, 2020
Charlson comorbidity index as a predictor of short-term outcomes after pulmonary resectionWeipeng Shao, Zhenrong Zhang, Jun Zhang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 14, 2010
[Effects of multiple factors on the prognosis of pIIIa/N2 patients with non-small cell lung cancer]Zhenrong Zhang, Deruo Liu, Yongqing Guo, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 4, 2010
Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2)Qianli Ma, Deruo Liu, Yongqing Guo, et al.
Pathology, Research and Practice|May 16, 2022
E2F1-activated LINC01224 drives esophageal squamous cell carcinoma cell malignant behaviors via targeting miR-6884-5p/DVL3 axis and activating Wnt/β-catenin signaling pathwayGuangliang Qiang, Qiduo Yu, Kunsong Su, et al.
Translational Cancer Research|February 4, 2022
Knockdown of actin-like 8 inhibits cell proliferation by regulating FOXM1, STMN1, PLK1, and BIRC5 in lung adenocarcinoma A549 cellsShanwu Ma, Guangliang Qiang, Weipeng Shao, et al.
The Annals of Thoracic Surgery|August 6, 2013
Extensive invasion of the left atrium by lung cancerQianli Ma, Deruo Liu, Peng Liu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|March 29, 2018
[Impact of Chronic Obstructive Pulmonary Disease on Risk of Recurrence in Patients with Resected Non-small Cell Lung Cancer]Guangliang Qiang, Qiduo Yu, Chaoyang Liang, et al.
Pageof 11